SITC Resource Library

2021-2022 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody Drug Conjugates 

02-16-2022 11:39

Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy Series - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates held virtually on February 10, 2022 are available here.


Program Organizers

  • Christian Capitini, MD – University of Wisconsin-Madison
  • Hope S. Rugo, MD – University of California San Francisco Comprehensive Care Center


Program Summary


Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty. 


Program Learning Objectives 

  • Describe the mechanisms of monoclonal antibodies and antibody-drug conjugates.
  • Summarize recent updates in the use of monoclonal antibodies and antibody-drug conjugates clinically and toxicity management for key disease states.
  • Outline common toxicities with monoclonal antibodies and antibody-drug conjugates and their management


Please note on-demand recordings are not available for continuing education credits.

#AdvancesinCancerImmunotherapy(ACI)#2022#MonoclonalAntibodies#AntibodyDrugConjugates#PresentationSlides#Video

Statistics
0 Favorited
118 Views
14 Files
0 Shares
57 Downloads

 Video
Attachment(s)
mp4 file
"Lymphoma and Leukemia Updates" - Video   142.66 MB   1 version
Uploaded - 02-23-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aaron Logan, MD, PhD - University of California San Francisco; Date: February 10, 2022;
pdf file
"Lymphoma and Leukemia Updates" - Slides   6.30 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aaron Logan, MD, PhD - University of California San Francisco; Date: February 10, 2022;
mp4 file
"HER2 Targeting for Non-Breast Malignancies Updates" - Video   93.80 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: David Ilson, MD, PhD - Memorial Sloan Kettering Cancer Center; Date: February 10, 2022;
pdf file
"HER2 Targeting for Non-Breast Malignancies Updates" - Sl...   4.00 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: David Ilson, MD, PhD - Memorial Sloan Kettering Cancer Center; Date: February 10, 2022;
mp4 file
"Urothelial Updates" - Video   45.32 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Daniel P. Petrylak, MD- Yale School of Medicine; Date: February 10, 2022;
pdf file
"Urothelial Updates" - Slides   2.59 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Daniel P. Petrylak, MD- Yale School of Medicine; Date: February 10, 2022;
mp4 file
"Pediatric Updates" - Video   107.77 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Patrick A. Brown, MD - John Hopkins University; Date: February 10, 2022;
pdf file
"Pediatric Updates" - Slides   2.72 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Patrick A. Brown, MD - John Hopkins University; Date: February 10, 2022;
mp4 file
Antibody Drug Conjugates" - Video   165.56 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Komal Jhaveri, MD, FACP - Memorial Sloan Kettering Cancer Center; February 10, 2022;
pdf file
Antibody Drug Conjugates" - Slides   4.06 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Komal Jhaveri, MD, FACP - Memorial Sloan Kettering Cancer Center; February 10, 2022;
mp4 file
Emerging Toxicities and Management Strategies in Breast ...   85.69 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aditya Bardia, MD, MPH - Massachusetts General Hospital; February 10, 2022;
pdf file
Emerging Toxicities and Management Strategies in Breast ...   1.69 MB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aditya Bardia, MD, MPH - Massachusetts General Hospital; February 10, 2022;
mp4 file
Faculty Discussion" - Video   124.04 MB   1 version
Uploaded - 02-23-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aditya Bardia, MD, MPH – Massachusetts General Hospital; Patrick A. Brown, MD – Johns Hopkins University; Christian M. Capitini, MD – University of Wisconsin-Madison; David Ilson, MD, PhD – Memorial Sloan Kettering Cancer Center; Hope S. Rugo, MD – University of California San Francisco Comprehensive Care Center; February 10, 2022;
pdf file
Faculty Discussion" - Slides   1007 KB   1 version
Uploaded - 02-16-2022
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aditya Bardia, MD, MPH – Massachusetts General Hospital; Patrick A. Brown, MD – Johns Hopkins University; Christian M. Capitini, MD – University of Wisconsin-Madison; David Ilson, MD, PhD – Memorial Sloan Kettering Cancer Center; Hope S. Rugo, MD – University of California San Francisco Comprehensive Care Center; February 10, 2022;

Related Entries and Links

No Related Resource entered.